Cardio Diagnostics Quote - CDIO

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.4968

Bid

0.49

Ask

0.4968

Volume

1,546,127

0.4575 Day's Range 0.5597

0.19 52 Week Range 1.77

Market Cap

25.906M

Previous Close

0.5199

Open

0.55

Last Trade

0.4926

Last Trade Time

Financial Volume

US$ 783,150

VWAP

0.506524

Average Volume (3m)

1,288,567

Shares Outstanding

52,145,416

Dividend Yield

PE Ratio

-2.99

Earnings Per Share (EPS)

-0.16

Revenue

35k

Net Profit

-8.38M

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenet... Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease. Show more

Sector

Blank Checks

Industry

In Vitro,in Vivo Diagnostics

Headquarters

Dover, Delaware, USA

Founded

2021

Cardio Diagnostics Holdings Inc is listed in the Blank Checks sector of the NASDAQ with ticker CDIO. The last closing price for Cardio Diagnostics was US$0.52. Over the last year, Cardio Diagnostics shares have traded in a share price range of US$ 0.19 to US$ 1.77.

Cardio Diagnostics currently has 52,145,416 shares outstanding. The market capitalization of Cardio Diagnostics is US$27.11 million. Cardio Diagnostics has a price to earnings ratio (PE ratio) of -2.99.

Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology’s 74th Annual Scientific Session

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced its participation in...

Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven Precision Cardiovascular Medicine company, today announced that the Company has...

Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc. (NASDAQ:...

Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, today announced it will sponsor and...

Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

Preliminary CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc...

Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-powered precision cardiovascular medicine, today announced the launch of its...

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s...

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s...

Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company will...

Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-driven precision cardiovascular medicine, today announced the successful...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.1138	29.7127937337	0.383	0.5796	0.365	1016317	0.48279643	CS
4	0.0899	22.0938805603	0.4069	0.5796	0.28	864198	0.38259517	CS
12	0.0543	12.2711864407	0.4425	0.685	0.28	1288567	0.48430813	CS
26	0.2868	136.571428571	0.21	1.77	0.21	4239376	0.63125499	CS
52	-0.2532	-33.76	0.75	1.77	0.19	2514950	0.59141704	CS
156	-3.7532	-88.3105882353	4.25	8.4999	0.171	2988199	1.56586216	CS
260	-3.7532	-88.3105882353	4.25	8.4999	0.171	2988199	1.56586216	CS

CDIO - Frequently Asked Questions (FAQ)

What is the current Cardio Diagnostics share price?

The current share price of Cardio Diagnostics is US$ 0.4968

How many Cardio Diagnostics shares are in issue?

Cardio Diagnostics has 52,145,416 shares in issue

What is the market cap of Cardio Diagnostics?

The market capitalisation of Cardio Diagnostics is USD 27.11M

What is the 1 year trading range for Cardio Diagnostics share price?

Cardio Diagnostics has traded in the range of US$ 0.19 to US$ 1.77 during the past year

What is the PE ratio of Cardio Diagnostics?

The price to earnings ratio of Cardio Diagnostics is -2.99

What is the cash to sales ratio of Cardio Diagnostics?

The cash to sales ratio of Cardio Diagnostics is 685.71

What is the reporting currency for Cardio Diagnostics?

Cardio Diagnostics reports financial results in USD

What is the latest annual turnover for Cardio Diagnostics?

The latest annual turnover of Cardio Diagnostics is USD 35k

What is the latest annual profit for Cardio Diagnostics?

The latest annual profit of Cardio Diagnostics is USD -8.38M

What is the registered address of Cardio Diagnostics?

The registered address for Cardio Diagnostics is 8 THE GREEN, SUITE #12490, DOVER, DELAWARE, 19901

Which industry sector does Cardio Diagnostics operate in?

Cardio Diagnostics operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WWWW International Inc	US$ 0.395 (167.62%)	223.58M
OMEXOdyssey Marine Exploration Inc	US$ 1.4979 (75.79%)	285.65M
RTCBaijiayun Group Ltd	US$ 0.3244 (74.88%)	263.23M
GREEGreenidge Generation Holdings Inc	US$ 1.3197 (53.92%)	5.84M
SXTCChina SXT Pharmaceuticals Inc	US$ 2.28 (44.30%)	38.04M
CGTLCreative Global Technology Holdings Ltd	US$ 1.5197 (-75.09%)	3.88M
TOIIWOncology Institute Inc	US$ 0.1015 (-40.22%)	156.14k
COEPCoeptis Therapeutics Holdings Inc	US$ 7.70 (-38.25%)	716.99k
INTSIntesity Therapeutics Inc	US$ 0.56 (-37.78%)	3.21M
SMMTSummit Therapeutics Inc	US$ 23.47 (-36.05%)	24.67M
GNLNGreenlane Holdings Inc	US$ 0.012699 (-15.34%)	355.22M
AGMHAGM Group Holdings Inc	US$ 0.0477 (22.31%)	340.91M
OMEXOdyssey Marine Exploration Inc	US$ 1.4979 (75.79%)	285.65M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 10.455 (19.62%)	266.95M
RTCBaijiayun Group Ltd	US$ 0.3244 (74.88%)	263.23M